Cargando…
Overtreatment in rheumatoid arthritis: are there reasons for concern?
Autores principales: | Ferreira, Ricardo J O, Gossec, Laure, da Silva, Jose Antonio Pereira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528607/ https://www.ncbi.nlm.nih.gov/pubmed/36180100 http://dx.doi.org/10.1136/rmdopen-2022-002212 |
Ejemplares similares
-
Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients
por: Duarte, Catia, et al.
Publicado: (2021) -
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis
por: Gossec, Laure, et al.
Publicado: (2015) -
Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial
por: Sigaux, Johanna, et al.
Publicado: (2017) -
Glucocorticoids and chronotherapy in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2016) -
Management of Fatigue in Rheumatoid Arthritis
por: Pope, Janet E
Publicado: (2020)